Worth Venture Partners, LLC Cellectar Biosciences, Inc. Transaction History

Worth Venture Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$4.6 - $7.8 $1.16 Million - $1.97 Million	252,570 Added 122.8%	458,245 $315,000
Q4 2021 Feb 14, 2022	BUY	$6.1 - $10.2 $1.25 Million - $2.1 Million	205,675 New	205,675 $137,000
Q4 2020 Feb 17, 2021	SELL	$11.2 - $27.7 $1.96 Million - $4.86 Million	-175,350 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$10.6 - $16.6 $2.37 Million - $3.71 Million	-223,776 Reduced 56.07%	175,350 $218,000
Q2 2020 Aug 14, 2020	BUY	$10.3 - $17.3 $4.11 Million - $6.9 Million	399,126 New	399,126 $511,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $12.5M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.